Market - Page 6 of 326 - Express Pharma

GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032

China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024

Cadila Pharmaceuticals launches Empadon (Empagliflozin)

Quadria Capital closes oversubscribed $1 bn fund III to advance healthcare across Asia

Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan

Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR

Barentz acquires Fengli, China, aims to strengthen market presence

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD: GlobalData

US drug pricing order – Implications for India’s pharma sector

Gene therapies drive growth of genomics market, says GlobalData